And here was my first television and my first cartoon and my first superhero — a hero who like my father, was in America—and somehow it all came together for me in a lightning bolt of longing and imagination. My fathers’ absence made perfect sense. He couldnt come back right away because he was busy fighting crime in NYC...as Spider–Man. The diasporic imagination really is its own superpower...I believed I had seen my father on that TV, and if I paid close enough attention it would show him to me again...For the record: my father did eventually return and take us to the States...My father was the worst shock of all. He had no problem laying hands on us kids for the slightest infraction. Beatings like he was making up for lost time. Like he was mad that he had a family...Are you surprised, then, that I was drawn back to the television? Because I was lost, because I wanted help with my English, because my father was a nightmare. And because I was convinced, foolish little fantasist that I was, that somehow my family and I had ended up in the wrong America and that the country and the father I’d first glimpsed on TV in Santo Domingo, the country and father I’d been promised, was still out there somewhere. I just had to find them. Never did.
Another study of 5 mg/day norethisterone in 132 women also made no mention of androgenic side effects. These findings suggest little to no risk of androgenic side effects with norethisterone at a dosage of 5 mg/day. A study of 194 women treated with 5 to 15 mg/day NETA for a median duration of 13 months of therapy to suppress symptoms of endometriosis observed no side effects in 55.2% of patients, weight gain in 16.1%, acne in 9.9%, mood lability in 8.9%, hot flashes in 8.3%, and voice deepening in two women (1.0%). Estrogenic
Norethisterone is weakly estrogenic (via conversion into its metabolite EE), and for this reason, it has been found at high dosages to be associated with high rates of estrogenic side effects such as breast enlargement in women and gynecomastia in men, but also with improvement of menopausal symptoms in postmenopausal women. It has been suggested that very high dosages (e.g., 40 mg/day, which are sometimes used in clinical practice for various indications) of NETA (and by extension norethisterone) may result in an increased risk of venous thromboembolism (VTE) analogously to high dosages (above 50 μg/day) of EE, and that even doses of NETA of 10 to 20 mg, which correspond to EE doses of approximately 20 to 30 μg/day, may in certain women be associated with increased risk. A study also found that ethinylestradiol and norethisterone had a greater influence on coagulation factors when the dose of norethisterone was 3 or 4 mg than when it was 1 mg.